KASMEJ
Kastamonu Medical Journal

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

ISSN: Passive
eISSN: 2757-9336
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Screening patients with metabolic syndrome for risk of obstructive sleep apnea: the syndrome Z
Abstract
Aims: Syndrome Z is defined as the coexistence of obstructive sleep apnea (OSA) and metabolic syndrome. As family medicine takes on the role of preventive medicine, syndrome Z is gaining importance in primary care. We aimed to determine the prevalence of syndrome Z in primary care by examining the risk of OSA in individuals with metabolic syndrome.
Methods: A cross-sectional study of patients diagnosed with metabolic syndrome according to NCEP-ATP III criteria was conducted at the Family Health Center. Patients' anthropometric measurements (waist circumference, neck circumference, height, and weight) were recorded. OSA risk assessment scales included the Berlin and STOP-BANG questionnaires, which have been shown in studies to be more sensitive tests and were therefore selected for use in our study.
Results: Of 156 participants, 37.8% (n=59) were at high risk for OSA on both questionnaires. According to STOP-BANG, 57.4% of men and 31.6% of women were at high risk, which was statistically significant. No association was found between OSA and diabetes, hypertension, and dyslipidemia. However, in both questionnaires, obesity and high body mass index significantly increased the risk of OSA. The area under the curve (AUC) was 0.649 with a specificity of 80.6% using a cut-off of 34.5 kg/m² for BMI.
Conclusion: Obese individuals with metabolic syndrome should be assessed for syndrome Z in primary care settings and preventive services should be offered to those at risk.

Keywords : Metabolic syndrome, obstructive sleep apnea syndrome, primary care, screening, syndrome Z

Download Article


1. Saraç S, Afsar GC. Effect of mean apnea-hypopnea duration in patients with obstructive sleep apnea on clinical and polysomnography parameter. Sleep Breath. 2020; 24(1):77-81. doi:10.1007/s11325-019-01870-y
2. Azarbarzin A, Sands SA, Younes M, et al. The sleep apnea-specific pulse-rate response predicts cardiovascular morbidity and mortality. Am J Respir Crit Care Med. 2021;203(12):1546-1555. doi:10.1164/rccm. 202010-3900OC
3. Li M, Li X, Lu Y. Obstructive sleep apnea syndrome and metabolic diseases. Endocrinology. 2018;159(7):2670-2675. doi:10.1210/en.2018-00248
4. Lee JJ, Sundar KM. Evaluation and management of adults with obstructive sleep apnea syndrome. Lung. 2021;199(2):87-101. doi:10.1007/s00408-021-00426-w
5. Solecka Š, Matler K, Kostlivý T, Kubec V, Tomášková H, Betka J. A comparison of the reliability of Five Sleep Questionnaires for the detection of obstructive sleep apnea. Life (Basel). 2022;12(9):1416. doi:10. 3390/life12091416
6. Le Grande MR, Jackson AC, Beauchamp A, Kerr D, Driscoll A. Diagnostic accuracy and suitability of instruments that screen for obstructive sleep apnoea, insomnia and sleep quality in cardiac patients: a meta-analysis. Sleep Med. 2021;86:135-160. doi:10.1016/j.sleep.2021.02.021
7. Kränkel N, Bahls M, Van Craenenbroeck EM, et al. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: how does it work? Eur J Prev Cardiol. 2019; 26(7):701-708. doi:10.1177/2047487318805158
8. Türkiye Endokrinoloji ve Metabolizma Derneği. Obezite Tanı ve Tedavi Kılavuzu [Obesity Diagnosis and Treatment Guideline] Ankara: TEMD. 2019; [Available from: https://file.temd.org.tr/Uploads/publications/guides/documents/20190506163904-2019tbl_kilavuz5ccdcb9e5d.pdf?a=1
9. Ambroselli D, Masciulli F, Romano E, et al. New advances in metabolic syndrome, from prevention to treatment: the role of diet and food. Nutrients. 2023;15(3):640. doi:10.3390/nu15030640
10. Chaudhary P, Goyal A, Goel SK, et al. Women with OSA have higher chances of having metabolic syndrome than men: effect of gender on syndrome Z in cross sectional study. Sleep Med. 2021;79:83-87. doi:10. 1016/j.sleep.2020.12.042
11. Borel AL. Sleep apnea and sleep habits: relationships with metabolic syndrome. Nutrients. 2019;11(11):2628. doi:10.3390/nu11112628
12. Wang F, Xiong X, Xu H, et al. The association between obstructive sleep apnea syndrome and metabolic syndrome: a confirmatory factor analysis. Sleep Breath. 2019;23(3):1011-1019. doi:10.1007/s11325-019-01804-8
13. Bonsignore MR, Baiamonte P, Mazzuca E, Castrogiovanni A, Marrone O. Obstructive sleep apnea and comorbidities: a dangerous liaison. Multidiscip Respir Med. 2019;14:8. doi:10.1186/s40248-019-0172-9
14. Nwankwo M, Okamkpa CJ, Danborno B. Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: a case study from urban southeast Nigeria. Diabetes Metab Syndr. 2022;16(12):102665. doi:10.1016/j.dsx. 2022.102665
15. Ong TH, Raudha S, Fook-Chong S, Lew N, Hsu AA. Simplifying STOP-BANG: use of a simple questionnaire to screen for OSA in an Asian population. Sleep Breath. 2010;14(4):371-376. doi:10.1007/s11325-010-0350-7
16. Acar HV, Kaya A, Yücel F, et al. Validation of the STOP-BANG Questionnaire: an obstructive sleep apnoea screening tool in Turkish population. Turk J Anaesthesiol Reanim. 2013;41(4):115-120. doi:10.5152/TJAR.2013.46
17. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131(7):485-491. doi:10.7326/0003-4819-131-7-199910050-00002
18. Ulasli SS, Gunay E, Koyuncu T, et al. Predictive value of Berlin Questionnaire and Epworth Sleepiness Scale for obstructive sleep apnea in a sleep clinic population. Clin Respir J. 2014;8(3):292-296. doi:10.1111/crj.12070
19. Song SO, He K, Narla RR, Kang HG, Ryu HU, Boyko EJ. Metabolic consequences of obstructive sleep apnea especially pertaining to diabetes mellitus and insulin sensitivity. Diabetes Metab J. 2019;43(2):144-155. doi:10.4093/dmj.2018.0256
20. Ahmed AM, Nur SM, Xiaochen Y. Association between obstructive sleep apnea and resistant hypertension: systematic review and meta-analysis. Front Med (Lausanne). 2023;10:1200952. doi:10.3389/fmed. 2023.1200952
21. Conradt R, Redhardt F, Beutel B, et al. Predisposing factors of daytime sleepiness in obese OSA patients. J Sleep Res. 2022;31:e13458. doi:10.1111/jsr.13458
22. Varghese L, Rebekah G, Oliver A, Kurien R. Oxygen Desaturation Index as alternative parameter in screening patients with severe obstructive sleep apnea. Sleep Sci. 2022;15 (Spec 1):224-228. doi:10.5935/1984-0063. 20200119
23. Oliveros H, Lobelo R, Giraldo-Cadavid LF, et al. BASAN index (Body-mass index, age, sex, arterial hypertension and neck circumference) predicts severe apnoea in adults living at high altitude. BMJ Open. 2021; 11(6):e044228. doi:10.1136/bmjopen-2020-044228
24. G&uuml;m&uuml;ştakim RŞ, Ayhan Baser D, Cevik M, et al. Evaluation of sleep quality, insomnia severity and OSAS risk in primary care population: a descriptive study. Int J Clin Pract. 2021;75(2):e13786. doi:10.1111/ijcp. 13786 </ol> <p>
Article available in :
Volume 5, Issue 3, 2025
Page : 145-149
https://doi.org/10.51271/KMJ-0200
Article Information
Received : 08 Eki 2024
Accepted : 15 Oca 2025
Published : 03 Eyl 2025
Corresponding Author :

Mustafa Bayraktar: Department of Family Medicine, Faculty of Medicine, Atatürk University, Erzurum, Turkiye

[email protected]
Citation : Aydemir HA, Bayraktar M. Screening patients with metabolic syndrome for risk of obstructive sleep apnea: the syndrome Z. Kastamonu Med J. 2025;5(3):145-149.

Read: 292
Download : 754
Cited: 0
_Footer